Francesco Pierconti
Università Cattolica del Sacro Cuore, Agostino Gemelli University Polyclinic
Papers
6
Total Citations
114
H-Index
5
About
Francesco Pierconti is a leading figure in robotic urologic surgery, with a research focus centered on the comparative effectiveness, technical refinement, and clinical outcomes of novel robotic platforms. His major contributions include pioneering the first large-scale comparative analysis of the Hugo™ RAS system against the established da Vinci platform for robot-assisted radical prostatectomy (RARP), demonstrating non-inferior perioperative and early functional outcomes. His work has been instrumental in defining the learning curves for multi-surgeon teams, specifically analyzing site-specific positive surgical margins to improve training protocols. Pierconti has also advanced the field of nephron-sparing surgery, showing that a purely off-clamp robotic approach for partial nephrectomy achieves superior pentafecta outcomes compared to open surgery. With over 100 citations across his most influential papers, his 2024 meta-analysis on the Hugo RAS system has already garnered 30 citations, marking it as a seminal reference. His notable achievements include leading the first monocentric series of 132 consecutive Hugo™ RAS prostatectomies at a tertiary referral center, establishing a benchmark for the safe adoption of emerging robotic technologies in urology.
Research Focus
Key Achievements
Top Papers
- 1
- 2Robotic versus Open Pyeloplasty: Perioperative and Functional Outcomes26 citations · 2023
- 3
- 4
- 5
- 6